Dow, S&P 500, Nasdaq drift as Wall Street braces for revision to jobs data

US stock futures trod water on Tuesday as investors waited for a revision to jobs numbers, seen as likely to show further labor-market weakness that could reset expectations for interest-rate cuts.

Dow Jones Industrial Average futures (YM=F) nudged up 0.1%, while those on the S&P 500 (ES=F) gained 0.2%. Contracts on the tech-heavy Nasdaq 100 (NQ=F) also put on roughly 0.2%, after stocks rose on Monday to stay in record-high territory.

Markets are treading cautiously on Tuesday as a revised look at US employment looms, with the regular update taking higher economic and political prominence than usual. Economists predict the Bureau of Labor Statistics will slash about 700,000 jobs from the level of employment for the year to March 2025.

The data lands as debate reigns over how the Federal Reserve will react after a slew of indications that the labor market is slowing down. Those signs have convinced traders that an interest-rate cut is coming when Fed policymakers meet next week. Now the question has shifted to how large the reduction might be, and whether that will be a boon for stocks.

Reports on inflation crucial to Fed thinking are due later in the week, with the latest reading of the producer price index (PPI) on Wednesday and the consumer price index (CPI) on Thursday. The CPI and PPI readings will shine light on whether rising prices could become a significant stumbling block to deep or sustained rate cuts.

Also in focus is Apple’s (AAPL) annual fall event, where the tech giant is expected to showcase devices including the iPhone 17 and iPhone Air, as well as new watches and heart rate-tracking AirPods. Experts question whether the smartphone updates can generate enough consumer interest to drive up sales, especially following a tariff-fueled buying frenzy earlier this year.

Elsewhere on the corporate front, shares of Tourmaline Bio (TRML) and Nebius (NBIS) both jumped over 50% in premarket trading on deal news, with Swiss pharma giant Novartis (NVS, NOVN.SW) and Big Tech Microsoft (MSFT) respectively.

Oracle (ORCL) and GameStop (GME) are set to report earnings after the bell.

LIVE 8 updates

  • Brian Sozzi

    Goldman Sachs Tech Conference Takeaways: Day 1

    Day 1 is in the books for me at the big Goldman Sachs tech and media conference in San Francisco — I’m prepping as we speak for a super-busy Day 2.

    A couple of worthwhile takeaways from my convos:

    Some key live chats on Yahoo Finance coming up today:

    Tune in here! More convos with Salesforce CEO Marc Benioff, CoreWeave CEO Michael Intrator, and Affirm CEO Max Levchin will be dropping Wednesday morning on Yahoo Finance.

  • Jenny McCall

    Good morning. Here’s what’s happening today.

  • The Fed still has the power to juice the market

    There’s a lot of market noise in the Federal Reserve’s quiet period ahead of its policy meeting next week, Yahoo Finance’s Hamza Shaban notes in today’s Morning Brief.

    He reports:

    Read more here.

  • Why Wall Street and Washington will be closely watching today’s jobs revisions

    A revised look at America’s jobs landscape over the last year is coming Tuesday morning, with a number that is widely expected to rip through economic and political circles.

    Yahoo Finance’s Ben Werschkul reports:

    Read more here.

  • Jenny McCall

    Premarket trending tickers: Nebius, Fox and Dell

    Here’s a look at some of the top stocks trending in premarket trading:

    Nebius Group (NBIS) stock rose 50% before the bell on Tuesday after announcing it had signed a AI deal with Microsoft (MSFT) worth $17.4 billion on Monday.

    Fox (FOX) shares fell 4% premarket following the Murdoch family reaching a deal that will see Rupert Murdoch’s eldest son Lachlan Murdoch take control of the family media empire that includes Fox News and the Wall Street Journal.

    Dell (DELL) shares fell 1% before the bell following the departure of the tech company’s CFO, Yvonne McGill.

  • Tourmaline stock surges after $1.4B Novartis deal

    Tourmaline Bio (TRML) shares soared over 50% in premarket after Novartis (NVS, NOVN.SW) said it is buying the US company in a $1.4 billion deal.

    The Swiss pharma giant will pay $48 a share for Tourmaline, with the deal expected to close in the fourth quarter.

    Novartis stock slipped slightly on Wall Street and in Switzerland.

    Reuters reports:

    Read more here.

  • Apple’s annual Phone event is happening today. Here’s what to expect.

    Apple (AAPL) opens the doors to its annual fall event at its Cupertino, Calif., headquarters, where the company is expected to debut its latest iPhone and Apple Watch lineups later Tuesday.

    Yahoo Finance’s Daniel Howley lays out what to expect at the show:

    Read more here.

  • Gold touches new record overnight

    Gold (GC=F) reached a new record overnight Monday into early Tuesday morning, buoyed by optimism over a rate cut at the Fed’s meeting next week.

    Bloomberg reports:

    Read more here.

Source link

Visited 1 times, 1 visit(s) today

Related Article

The Emerging Ellison Empire

The Emerging Ellison Empire

Paramount Skydance chief executive David Ellison. (Photo by Charly Triballeau/AFP via Getty Images) On Thursday afternoon, the media world was jolted by a scoop from The Wall Street Journal: Paramount is preparing a majority cash bid for Warner Bros. Discovery, backed by the immense wealth of the Ellison family. The offer would cover the entire

A row of Nebius' data center servers.

Why Nebius Stock Is Rocketing Higher This Week

Nebius just inked a deal with Microsoft worth more than the total value of the company. Nebius Group (NBIS -4.57%) surprised investors with a big business deal, sending its stock soaring by nearly 50% on Tuesday. As of Thursday afternoon trading, Nebius shares were up by 40% for the week, according to data provided by

Adobe Stock Price Target Cut to $460 by Oppenheimer Ahead of Q3 Earnings

Adobe Inc. (NASDAQ:ADBE) is one of theĀ AI Stocks In The Spotlight For Investors. On September 9, Oppenheimer analyst Brian Schwartz lowered the price target on the stock to $460.00 (from $500.00) while maintaining an Outperform rating. The rating, issued as part of a fiscal Q3 earnings preview, reflects low expectations into the earnings print considering

Oracle's concentration risk

Oracle shares retreat 6% after sharpest rally in more than 30 years

Safra A. Catz, CEO of Oracle, on Oct. 7, 2024. Marco Bello | Reuters Oracle shares closed down 6% on Thursday, a day after the stock closed at a record high, following an analyst note expressing concern that most of the company’s upcoming growth is coming from a single client: OpenAI. The software vendor has

GBP/USD chart

British Pound ahead of GDP data release

The British Pound (GBP) is trending flat against the US Dollar (USD) on Thursday, trading at 1.3535 despite a spike in volatility following the release of US inflation data. Traders are now turning their attention to the release of UK Gross Domestic Product (GDP) data for July, due on Friday at 06:00 GMT. GDP is

ET logo

Infosys announces its biggest-ever share buyback of Rs 18,000 crore at 19% premium

Leading IT services player Infosys Ltd on Thursday announced a buyback of Rs 18,000 crore through a tender route, its biggest ever since listing. The Bengaluru-based IT major will buyback about 10 crore shares, representing 2.41% of equity at Rs 1,800 apiece, which will be 19% premium over the current market price. Under a buyback

Infosys to Buy Back $2 Billion of Stock After Share Price Slump

A logo at the headquarters of Infosys Ltd. in Bengaluru, India, on Thursday, April 17, 2025. Infosys Ltd. predicted slowing sales growth for this year, as corporations curtail large information technology projects to prepare for geopolitical and economic challenges. Photographer: Karen Dias/Bloomberg (Bloomberg) — Indian software services giant Infosys Ltd. will buy back as much

This Venture Firm Is the Biggest Winner in Figure's IPO

This Venture Firm Is the Biggest Winner in Figure’s IPO

When DCM wrote the first institutional check into Figure Technologies, the Menlo Park-based venture firm was making a risky bet on both an unproven use of blockchain technology and a founder with a checkered past. Nearly eight years later, that decision is set to deliver one of DCM’s biggest wins: a stake worth nearly 60x